Medicis Pharmaceutical Corp (MRX)
A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.
Recs
kenc132000
(90.84)
Submitted: 3/18/2009 11:39:33 AM :
Start Price:
$9.09
MRX Score:
+116.07
New 52 week low. Double down on losing position.
Recs
wtcrane1
(93.31)
Submitted: 1/5/2009 2:56:20 PM :
Start Price:
$13.63
MRX Score:
+52.88
Dirt cheap. Ripe for a takeover.
Recs
sandvig
(99.67)
Submitted: 12/24/2008 11:17:47 AM :
Start Price:
$13.80
MRX Score:
+42.46
Going long on pimples and wrinkles. They cover the bases from teens to pre-geezers.
Recs
BlindSkuirrel
(70.94)
Submitted: 12/2/2008 1:27:19 PM :
Start Price:
$13.08
MRX Score:
-48.13
A spike on good news is never good news ;/
Recs
trovak79
(< 20)
Submitted: 10/2/2008 12:43:54 PM :
Start Price:
$14.29
MRX Score:
+65.55
Cash/share = price
Recs
comet9
(< 20)
Submitted: 7/13/2008 6:37:25 PM :
Start Price:
$18.53
MRX Score:
+37.26
Slowed growth in earnings due to increased expenses with LipoSonix acquisition. Whether that business takes off or not, there is very good value here.
Recs
NASAGeek
(95.31)
Submitted: 6/26/2008 9:21:56 PM :
Start Price:
$19.79
MRX Score:
+31.25
magicformulainvesting.com screen at $153M market cap, top 25 companies on June 26, 2008
Recs
Richthofen80
(94.08)
Submitted: 6/22/2008 12:41:30 PM :
Start Price:
$20.87
MRX Score:
+27.51
Pure speculation on the Liposonix acquisition. Surgery free fat removal has huge potential if FDA approves. If not, at least they get international exposure because the process is already approved in Europe.
Recs
healthcarevalue
(94.46)
Submitted: 6/20/2008 12:05:36 AM :
Start Price:
$20.86
MRX Score:
+28.18
1.2B market cap, price/earnings of 16 is okay, debt/equity of 0.7 is meh, but greater than 100% return on capital is nice, and the niche market and company's strategic alliances don't hurt either.
Recs
angus118
(< 20)
Submitted: 5/14/2008 5:27:31 PM :
Start Price:
$22.58
MRX Score:
+24.08
magic formula pick. buy@22.78 and check in a year.
Recs
kulls81
(35.51)
Submitted: 5/8/2008 11:56:17 PM :
Start Price:
$20.46
MRX Score:
+33.29
MFI 200+, 4 stars
Recs
Colli002
(57.01)
Submitted: 5/6/2008 6:50:13 AM :
Start Price:
$19.90
MRX Score:
+37.54
Biotechnology play - great intrinsic value ratio
Recs
Recs
MD4Beauty
(< 20)
Submitted: 11/13/2007 5:48:42 PM :
Start Price:
$27.38
MRX Score:
-9.31
Medicis has been given a strong buy recommendation by Standard and Poor's analysts citing their new products for acne treatment and their strong market share in dermal fillers (Restylane and Perlane). From someone in the trenches of treating acne, I have been underwhelmed by the new Ziana and Solodyne products. These don't seem like the right fuel to launch a rocket to soaring profits. The Restylane product will be getting more competition from Juvederm and Radiesse as well as other dermal fillers in the pipeline.
Recs
Mroczka11
(36.45)
Submitted: 10/11/2007 4:18:54 PM :
Start Price:
$27.81
MRX Score:
+11.05
Reloxin filing in Q4 plus Ziana and Perlane growth will drive earnings and stock higher.
Recs
3PO
(37.70)
Submitted: 10/6/2007 11:10:00 AM :
Start Price:
$29.48
MRX Score:
+6.21
S&P Fair Value @28.50
Recs
Ludraman1
(< 20)
Submitted: 9/20/2007 1:28:36 PM :
Start Price:
$30.00
MRX Score:
+3.18
dermatology products treating acne, acne-related conditions, fungal
infections, skin discoloration, and inflammatory and hyperproliferative skin diseases, such as psoriasis
and topical dermatitis.
People are increasingly concerned with appearance and willing to spend more money on anything that affects the skin.
Medical spending continues in a downturn too.
Recs
btincher
(47.21)
Submitted: 7/7/2007 5:43:19 AM :
Start Price:
$30.41
MRX Score:
+2.33
New, fairly affordable skin product now widely available. Replaces surgery for those who can't afford a plastic surgeon. Profits should take place by 4th quarter.
Recs
BaeslerCapital
(< 20)
Submitted: 5/5/2007 7:11:54 PM :
Start Price:
$30.36
MRX Score:
+0.99
Vanity play for all those retiring bankers.
you know who you are...
Recs
nickbaes
(90.05)
Submitted: 2/1/2007 2:40:20 PM :
Start Price:
$35.93
MRX Score:
-14.87
Vanity play for the baby boomers.
expected to earn 1.64 this coming year.
22 x that number is good considering where I feel that eps number is heading.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 24 1 2 Next »